Cell Origin Biotech (Hangzhou) Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Cell Origin Biotech (Hangzhou) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors (NCT06562647) | Cell Origin Biotech (Hangzhou) Co., Ltd. | 2023-04-12 |
Track Cell Origin Biotech (Hangzhou) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.